Best in Biotech 7 Nov 2024
Cystic fibrosis: Five biotechs breathing life into the therapeutic space
…replication deficient HSV-1–based platform that enables the development of gene therapies that can be administered with none to little invasion. HSV-1 is a virus that has a large genome, and…